Risk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand
- 18 August 2024
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 65 (13) , 2009-2015
Abstract
Tumor lysis syndrome (TLS) in childhood leukemia was assessed retrospectively in 252 patients in a single tertiary center in Thailand during 2009-2019. Fifty-one (20.2%) developed TLS during their induction chemotherapy; 60.7% (31/51) were spontaneous TLS and 47% (24/51) developed clinical TLS. The predictive score model consisted of white blood cell (WBC) count more than 50,000 cells/mm3, glomerular filtration rate less than 90, and aspartate transaminase more than 44 units/L. The TLS development rates were 11.1%, 46.2%, and 78.5% in the low, intermediate, and high-risk groups, respectively. Death during the first induction phase in patients with TLS was significantly higher than in the patients without TLS. However, the 5-year overall survival rates for the children with and without TLS were not significantly different.Keywords
This publication has 22 references indexed in Scilit:
- Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemiaScientific Reports, 2021
- Risk‐based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource‐limited settingPediatric Blood & Cancer, 2018
- Tumour genesis syndrome: severe hypophosphatemia and hypokalemia may be ominous presenting findings in childhood acute myeloid leukaemiaEuropean Journal of Pediatrics, 2017
- Life-threatening hypophosphatemia and/or phosphate depletion in a patient with acute lymphoblastic leukemia: a rare case reportThe American Journal of Emergency Medicine, 2014
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemiaCancer, 2011
- Tumour lysis syndrome in children: experience of last decadeHematological Oncology, 2011
- The Tumor Lysis SyndromeNew England Journal of Medicine, 2011
- Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndromeCancer, 2007
- Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemiaPediatric Blood & Cancer, 2004
- A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trialLeukemia, 2001